Title of article :
Efficacy of Cyclophosphamide versus Cyclosporine in Frequent Relapse Nephrotic Syndrome – A Hospital Based Study
Author/Authors :
Rahman, Habibur Department of Pediatric Nephrology - Bangabandhu Sheikh Mujib Medical University Dhaka, Bangladesh. 2Associate professor, Department of Pediatric Nephrology - Bangabandhu Sheikh Mujib Medical University Dhaka, Bangladesh , Huque, Saimul Department of Pediatric Nephrology - Bangabandhu Sheikh Mujib Medical University Dhaka, Bangladesh. 2Associate professor, Department of Pediatric Nephrology - Bangabandhu Sheikh Mujib Medical University Dhaka, Bangladesh , Rahman, Azizur Department of Pediatric Nephrology - Bangabandhu Sheikh Mujib Medical University Dhaka, Bangladesh. 2Associate professor, Department of Pediatric Nephrology - Bangabandhu Sheikh Mujib Medical University Dhaka, Bangladesh , Muinuddin, Golam Department of Pediatric Nephrology - Bangabandhu Sheikh Mujib Medical University Dhaka, Bangladesh. 2Associate professor, Department of Pediatric Nephrology - Bangabandhu Sheikh Mujib Medical University Dhaka, Bangladesh
Pages :
5
From page :
1
To page :
5
Abstract :
The clinical outcome of patients with Frequent Relapse Nephrotic Syndrome (FRNS) or Steroid Dependent Nephrotic Syndrome (SDNS) treated with cyclophosphamide or cyclosporine (CsA) is yet to be established. This study was carried out to compare the efficacy of CsA with cyclophosphamide in patients with FRNS or SDNS. Materials and Methods: A total of 54 FRNS or SDNS children were randomly enrolled in this prospective study from August 2013 to July 2014. All the study subjects were treated with prednisolone 60 mg/m2 /day until the patients were in remission for three consecutive days. The patients were then randomly divided into two groups (Group-A & Group-B). Group-A was treated with cyclophosphamide at a dose of 2.5 mg/kg/day for 60 days, along with tapering dose prednisolone for 8 weeks. The Group-B study population was treated with cyclosporine at a dose of 3 mg/kg/day for 6 months or longer along with tapering dose of alternate day prednisolone for the initial 8 weeks. Four patients in Group-B and one patient in Group-A did not continue the treatment. So, we followed-up 49 children during this period. Results: The ef
Keywords :
Cyclosporine , Cyclophosphamide , Nephrotic syndrome , Child
Journal title :
Astroparticle Physics
Serial Year :
2016
Record number :
2451742
Link To Document :
بازگشت